Quickly optimizing therapy
for patients with life-threatening infections is critical. Hours count, and you've been waiting for days. You need answers...
MicroPhage provides
answers to clinicians seeking to optimize antibiotic therapy earlier in the course of disease. MicroPhage products are dedicated to improving patient outcomes, decreasing length of hospital stay and enhancing antimicrobial stewardship.
The MicroPhage KeyPath™ MRSA/MSSA Blood Culture Test – empowering better treatment decisions through accelerated pathogen identification and antibiotic susceptibility. » more
FDA clears MicroPhage's KeyPath™ MRSA/MSSA Blood Culture Test to quickly diagnose and distinguish MRSA and MSSA. » more
With the MicroPhage MRSA/MSSA Screening Test clinicians can quickly and affordably screen patients for
methicillin-resistant and methicillin-susceptible S. aureus. » more